Flower One Holdings Inc. (CSE:FONE) (“Flower One” or the “Company”) is pleased to announce a property acquisition in North Las Vegas from an arm’s length third party for total cash consideration of $1.15 million to support its future retail presence. The property is a freestanding former bank building offering important security attributes beneficial to the Company’s retail strategy. The building is conveniently located within close proximity to the major retail corridor in North Las Vegas, the Cannery Hotel & Casino, the Company’s 455,000 square foot flagship cultivation and production facility, which is the largest in Nevada, and NLV Organic Inc.’s fully operational 25,000 square foot cultivation and production facility.

The Company has submitted applications for multiple Recreational Marijuana Establishment Licenses within the State of Nevada; an opportunity only available to existing operational cannabis license holders. The Nevada’s Department of Taxation anticipates awarding dispensary licenses to successful applicants in December 2018.


“Flower One’s core business in Nevada will continue to focus on cannabis cultivation, processing and high-volume packaging,” said Flower One’s President and CEO, Ken Villazor.  “However, we wanted to take full advantage of the rare opportunity to apply for these dispensary licenses given our eligibility.  Should our applications prove successful, we view the opportunity to operate a state-licensed dispensary as an effective way to better understand the cannabis consumers’ preferences in the highly evolving Las Vegas and Nevada market.”

The potential dispensary licenses would be in addition to the Company’s four existing licenses and the five additional licenses it expects to obtain through the acquisition of NLV Organics Inc., as announced on October 9, 2018, which is expected to close by the end of the year. This acquisition will include a fully operational 25,000 square foot cultivation and production facility with nine grow rooms capable of cultivating up to 4,500 plants per cycle.  When combined with the Company’s 80,000 plants per cycle, this combined 480,000 square feet of cultivation and production will result in annual cultivation of over 148,000 pounds.

About Nevada’s Fast-Growing Cannabis Market

Medical cannabis use in Nevada was legalized on November 7, 2000 and recreational (adult) use was legalized on July 1, 2017.  According to State officials, Nevada’s fast-growing marijuana industry had revenue in its first fully legalized year totaling $529.9 million, including $424.9 million for recreational use1. The Nevada cannabis market is driven largely by the tourism market which is estimated to be 55 million visitors per year2 with approximately 42 million of them visiting Las Vegas according to the Las Vegas Convention and Visitors Authority3.

The Nevada’s regulatory framework requires every 5 pounds of dry flower to be tested and approved by an independent, state-licensed laboratory before the product is cleared for retail or processing ensuring all products sold in the state provide consumers with a trusted, quality experience.  This has allowed the demand for cannabis to steadily grow since being fully legalized. Pricing remains stable given the limited number of cannabis licenses issued by the State of Nevada. For the period of July to December 2018, the State’s Department of Taxation has set the following Fair Market Value wholesale pricing:

  • Dry Flower Buds = USD $2,799 per lb
  • Dry Small Popcorn/Bud = USD $2,227 per lb
  • Dry Trim/Shake = USD $798 per lb

1https://tax.nv.gov/Publications/Marijuana_Statistics_and_Reports/
2https://travelnevada.com/press/press-releases/74/travelnevada-launches-fallwinter-marketing-campaign
3https://www.lvcva.com/stats-and-facts/visitor-statistics/ 

Informational Purposes Only

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the Flower One’s securities to, or for the account or benefit of, persons in any jurisdiction.

About Flower One Holdings Inc. (CSE: FONE)

Home to the largest commercial scale greenhouse in the State of Nevada, Flower One aims to leverage the industry’s leading agricultural technologies, utilizing innovative growing and sustainability practices to cultivate high-quality cannabis at scale for Nevada’s growing cannabis market. The Company is licensed for medical marijuana cultivation and production, and recreational marijuana cultivation and production in the state of Nevada. Once canopied, targeted Q1 2019, the 455,000 square foot facility will be used for cannabis cultivation as well as the processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.

Sustainably-cultivated cannabis at scale to meet Nevada’s growing demand, Flower One is ready to grow for you.

For further information about the Company, please visit their website at www.flowerone.com and follow @FlowerOneIRon Twitter.

Cautionary Note regarding Forward Looking Information

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Flower One’s public documents. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward- looking statements.

Forward-looking statements may include, without limitation, statements relating to the execution of the Company’s strategy, new opportunities, future growth, future retail presence and potential benefits of retail strategy, potential capabilities of the cultivation and processing facility in Nevada, potential closing of the transaction with NLV Organics Inc., the ability of the Company to acquire further licenses, future demand for and pricing of cannabis, potential partnering opportunities with cannabis consumer brands and profitability of the cannabis market in the United States.

Although Flower One has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under US federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Flower One Holdings disclaims any intention or obligationto update or revise such information, except as required by applicable law.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR THEIR REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

For further information: Investor Relations & Media, NATIONAL Equicom, 416.848.9835, ir@flowerone.com; Flower One Holdings Inc., Ken Villazor, President and CEO, 416.913.9642, kvillazor@flowerone.com

Source: www.newswire.ca

  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less